Navigation Links
New Mini-Documentary Exposes Psychiatric Drugs Turning Kids into Killers
Date:3/5/2008

54 Dead and 105 Wounded in Recent Teen and School Shootings

LOS ANGELES, March 5 /PRNewswire-USNewswire/ -- On February 14, Illinois gunman Steven Kazmierczak became the 12th shooter in the past decade under the influence of psychiatric drugs documented by international drug regulatory agencies to cause suicide, mania, psychosis, hallucinations, hostility and in the case of one antidepressant, "homicidal ideation." With casualties from school or teen shootings now totaling 54 dead and 105 wounded, the mental health watchdog Citizens Commission on Human Rights (CCHR) says it is time to stop vested interests from spouting their usual propaganda about psychiatric drugs, and instead demand a federal investigation for the sake of public safety. While the psychiatric/pharmaceutical industries have persisted in vehemently denying that antidepressants and other psychiatric drugs cause violence, CCHR is quick to point out that it was similar vested interests that stalled the FDA from issuing black box warnings on suicide for more than 13 years. (See video from 1991 FDA hearing. http://www.cchr.org/video/psychiatric_drugs/fda_hearing_1991.html)

In a new 11-minute documentary (http://www.cchr.org/school_shootings/index.html) entitled Psychiatry's Prescription For Violence, psychiatrists, psychologists, professors, attorneys and medical experts join CCHR in exposing the link between psychiatric drugs and acts of violence that have been buried by those putting profit before public safety. CCHR's battle for full public disclosure on the risks of these drugs spans nearly two decades and is chronicled in a new report (http://www.cchr.org/media/pdfs/Exposing_the_Dangers_of_Antidepressants_Des'/>"/>

SOURCE Citizens Commission on Human Rights
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Legal Momentum Publication Exposes How Abstinence-Only Programs Harm Women and Girls
2. Walter Reed Anniversary Exposes More McCain Double Talk
3. With the Largest-Ever Buyout of a National Nursing Home Chain Pending ... New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes
4. New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes
5. Biomarkers for Mood May Alter Psychiatric Treatments
6. Autoantibodies and neuropsychiatric events in lupus
7. Relatives of Parkinsons Patients at Higher Psychiatric Risk
8. Treating patients with psychiatric disorders for hepatitis C
9. Child mental health experts issue psychiatric medication treatment guidelines for preschoolers
10. Psychiatrists, parents significantly differ in ADHD, psychiatric comorbidities perceptions
11. Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ech firm Replikins Ltd. today issued its latest bi... It shows that the lethality of the virus has dro...rus,s current outbreak in the spring of 2009 to re....1). The H1N1 infectivity count, however, remains ...B) November 27, 2009 -- Biotech firm Replikins Ltd...
(Date:11/27/2009)... 27 The Gymboree Corpora..., CFO/COO, will present at the NASDAQ OMX 23rd Inv...Hotel in London, England, on Wednesday, December 2...ve broadcast of The Gymboree Corporation,s present...oree.com, click on "Our Company" at the bottom of ...
(Date:11/27/2009)...E, France, Nov. 27 Team Garmin-Sli...eam dedicated to ethical sporting and developing t... today that it will become Team Garmin-Transitions... sponsor of the team. Transitions Optical is the w...ffering the most advanced photochromic technology ...
(Date:11/27/2009)...Care Holdings has announced that it has become a n...f the largest nonprofit organizations dedicated to..., Delray Beach, FL (Vocus)...BB: XCHO), a company specializing in the marketing...oducts, has announced today that is has become a n...
(Date:11/27/2009)...dented medical, economic burdens, study predicts ,...he number of people with diabetes in the United St... a new study predicts. , That would bring the t... disease, up from 23.7 million today. , , At the...tes will triple, the study also warns, rising from...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
... Organize, Navigate the,Complicated Medical, Educa...ay, the Autism,Society of America (ASA) and MeadWe...nced they have partnered to design an autism-theme... April,1., MeadWestvaco and ASA -- the nation,s l...
...,Inc. (NYSE: NUS ) chief financial officer, Ritch...r Conference in New York City on Wednesday, March,...cast live beginning at 2:30 p.m.,(EDT). Those wish...hive of the webcast will be,available at this same...
...ng immune-system killer cells with a new pair of g... Medicine of Yeshiva University transformed them i...h HIV, the virus that causes AIDS. Their novel str... new approach for combating AIDS and other viral d...
...ther healthcare professionals,to work together to ... at,risk, PARK RIDGE, Ill., March 6 - In a decisi...York in which patients were,infected with hepatiti...s across the nation to exercise the utmost,care an...
... the Iowa Chronic Care Consortium, is recognized f...Medicaid population with chronic healt...y Pharos Innovations, a,remote patient monitoring ...rough contributions in transforming the health,of ...
...ascular threats, study suggests , , THURSD...cations for rheumatoid arthritis may also be reduc...tudy suggests. , People with rheumatoid arthritis...o hardening of the arteries. Heart attack and stro...
Other Medicine News:Health News:MeadWestvaco and Autism Society of America Launch 2008 ASA Autism Awareness Cambridge Planner 2Health News:MeadWestvaco and Autism Society of America Launch 2008 ASA Autism Awareness Cambridge Planner 3Health News:Einstein researchers genetically engineer immune cells into potent weapons for battling HIV 2Health News:Einstein researchers genetically engineer immune cells into potent weapons for battling HIV 3Health News:AANA Condemns Unsafe Injection Practices 2Health News:AANA Condemns Unsafe Injection Practices 3Health News:AANA Condemns Unsafe Injection Practices 4Health News:AANA Condemns Unsafe Injection Practices 5Health News:Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research 2Health News:Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research 3Health News:Rheumatoid Arthritis Drugs May Lower Heart Attack, Stroke Risk 2
(Date:11/25/2009)...JOHANNESBURG, November 25 ,iThemba ...ery announced today,that they have signed a collab..., services. , Pyxis,s world class computa... be coupled with iThemba,s service division to pro...projects identified through Pyxis,international c...
(Date:11/25/2009)...ewswire/ -- ChemoCentryx, Inc., announced today ... PROTECT-1 (the Prospective Randomized Oral Therap...-EN(TM) (CCX282-B) in patients with moderate-to-se...y with a favorable safety and tolerability profile...icacy in the reduction of disease severity as defi...
(Date:11/24/2009)...-- ,, WHAT: Rom Houbens, a Belgian man though...uto accident, was actually fully conscious and awa...Morning America segment. The DynaVox EyeMax was f...th Locked-in Syndrome and other conditions can unl...ca -- Tuesday, November 24 available online at ...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2DIA FDA PhRMA to Host Progression Free Survival Oncology Workshop 55448 1DIA FDA PhRMA to Host Progression Free Survival Oncology Workshop 55448 2DIA FDA PhRMA to Host Progression Free Survival Oncology Workshop 55448 3The Gaming Industry Stacks the Deck Against Smokefree Workplaces in Indiana 55444 1The Gaming Industry Stacks the Deck Against Smokefree Workplaces in Indiana 55444 2Movember Presents at LIVESTRONG 28R 29 Global Cancer Summit in Dublin Ireland in Support of Mens Health 55440 1Movember Presents at LIVESTRONG 28R 29 Global Cancer Summit in Dublin Ireland in Support of Mens Health 55440 2Movember Presents at LIVESTRONG 28R 29 Global Cancer Summit in Dublin Ireland in Support of Mens Health 55440 3
...ilotinib) Effective in 77% of Patients Resistant o...rly) Phase of Chronic,Myeloid Leukaemia (CML)(1), ...e Root Cause of CML,Whilst Providing an Acceptable...na Expands CML Portfolio for Novartis, Providing E...ients With Tasigna(R) and the CML,Gold-Standard, G...
...resent preliminary Phase II data for the adj... mechanically-ventilated patients,...ether with Nektar Therapeutics (Nasdaq: NKTR ), t...on their unique drug-device combination Amikacin,I...l meeting. Amikacin,Inhale, currently being studie...
Other Medicine Technology:Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 2Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 3Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 4Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 5Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7
Liquichek Autoimmune Controls - ANA
Lyphochek Assayed Chemistry Control
Lyphochek Benzo/TCA Control Set A
Lyphochek Benzo/TCA Control Set B
Medicine Products: